Role of IFI16 in Cellular Senescence
Role of IFI16 in Cellular Senescence
批准号:
7438836
负责人:
DIVAKER CHOUBEY
金额:
$23.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2010-04-30
关键词:
1q22AffectBindingBiochemical GeneticsBiological AssayCDKN1A geneCell AgingCell Cycle ArrestCellsDimerizationDiploidyDown-RegulationE2F1 geneEctopic ExpressionEpithelial CellsFibroblastsGene ExpressionGene TargetingGenesGenetic TranscriptionGrowthHeterochromatinHumanHuman Cell LineHypoxiaIonizing radiationLengthMediatingMolecularOncogenesPathway interactionsPost-Translational Protein ProcessingProtein BindingProtein FamilyProteinsRadiation Induced DNA DamageRegulationRoleSerumStressTERT geneTP53 geneTelomeraseTelomerase inhibitionTestingTranscriptional ActivationUp-Regulationbasec-myc Genescell growthcell growth regulationchromatin immunoprecipitationcobaltous chloridedesignexhaustin vivokeratinocytemutantnoveloncoprotein p21promoterresearch studysenescencetelomeretranscription factor
中文摘要
细胞衰老是指细胞耗尽后表现出的不可逆的细胞周期停滞
复制潜力。尽管P53、Rb和端粒磨损与细胞周期调控有关
衰老,导致不可逆的细胞周期停滞的分子机制,其特征是
基因表达的变化仍有待阐明。这些拟议研究的主要目的是了解
IFI16蛋白(由位于1q22的/F/76基因编码)作为诱导剂的分子机制
转录调节因子,参与细胞衰老相关的细胞周期停滞。
我们用人类上皮细胞和人类二倍体成纤维细胞(HDFS)进行的实验揭示了以前
IFI16在调节细胞衰老中的作用未知。然而,其分子机制仍不清楚。
根据我们的初步观察和其他观察,我们假设IFI16有助于细胞衰老-
通过与转录因子如P53、Rb-E2F和c-Myc相互作用以及通过调节
它们的转录活动。以下三个具体目标旨在检验我们的假设:目标1:
确定IFI16和P53之间的相互作用是否有助于p21基因的转录激活并限制
高密度脂蛋白纤维的增殖潜能。我们建议:(I)确定衰老与翻译后相关
IFI16和P53的修饰影响它们的物理相互作用;(Ii)确定IFI16的分子机制
增加p53介导的p21基因的转录激活;以及(Iii)比较IFI16对细胞生长的抑制
P5 3+/+与p5 3“‘~)或p2 1CIR1(p2 1+/+与p2 1”A)表达不同的等位基因HDF之间。遗传
并将使用包括染色质免疫沉淀分析(Chlps)在内的生化方法。目标2:达到
确定IFI16与Rb和E2F的相互作用是否增强了E2F靶基因的沉默。我们建议
确定:(I)IFI16是否以LxCxE依赖的方式与RB Pocket结合,以及Pocket突变体是否
与IFI16结合有缺陷;(Ii)IFI16与E2F-家族蛋白的结合抑制E2F的二聚化
与DP蛋白家族和E2F介导的转录有关;以及(Iii)IFI16增强RB介导的异染色质
E2F靶基因的形成和沉默,如hTERT。目的#3:阐明分子机制
其中IFI16负向调控hTERT基因的转录。我们将确定是否:(I)击倒IFI16
HDFS表达增加hTERT表达和端粒酶活性;(Ii)IFI16与c-Myc结合抑制
C-Myc与其伴侣Max的二聚化和c-Myc介导的转录;(Iii)增加或减少
在v/vov和c-Myc介导的hTERT转录中,IFI16的表达影响c-Myc与hTERT启动子结合
吉恩。我们提出的实验的意义在于,它们将确定IFI16
调节衰老相关基因的转录,参与衰老相关的细胞周期
逮捕。
英文摘要
Cellular senescence refers to the irreversible cell cycle arrest displayed by cells that have exhausted their
replicative potential. Although the p53, Rb, and telomere attrition have been implicated in the regulation of cellular
senescence, molecular mechanisms contributing to irreversible cell cycle arrest that is characterized by distinct
changes in gene expression remain to be elucidated. The main objective of these proposed studies is to understand
the molecular mechanisms by which IFI16 protein (encoded by the /F/76gene located at 1q22), an inducible
transcriptional regulator, contributes to cellular senescence-associated cell cycle arrest.
Our experiments using human epithelial cells and human diploid fibroblasts (HDFs) have revealed a previously
unknown role for IFI16 in the regulation of cellular senescence. However, the molecular mechanisms remain unknown.
Based on our preliminary and other observations, we hypothesize that IFI16 contributes to cellular senescence-
associated cell cycle arrest by interacting with transcription factors, such as p53, Rb-E2F, and c-Myc, and by regulating
their transcriptional activities. The following three specific aims are designed to test our hypothesis: Aim #1: To
determine whether interactions between IFI16 and p53 contribute to transcriptional activation of p21 gene and limit the
proliferative potential of HDFs. We propose to: (i) determine whether senescence-associated posttranslational
modifications of IFI16 and p53 affect their physical interactions; (ii)identify the molecular mechanisms by which IFI16
increases p53-mediated transcriptional activation of p21 gene; and (iii)compare inhibition of cell growth by IFI16
between isogenic HDFs differing in the expression of p53 (p53+/+ versus p53"'~) or p21CIR1 (p21+/+ versus p21"A). Genetic
and biochemical approaches, including chromatin immunoprecipitation assays (ChlPs), will be used. Aim# 2: To
determine whether interactions of IFI16 with Rb and E2F potentiate silencing of the E2F target genes. We propose to
determine whether: (i) IFI16 binds to Rb pocket in an LxCxE-motif-dependent manner and whether the pocket mutants
of Rb are defective in binding to IFI16; (ii)binding of IFI16 to the E2F-family of proteins inhibits dimerization of E2Fs
with DP-family of proteins and E2F-mediated transcription; and (iii) IFI16 potentiates the Rb-mediated heterochromatin
formation and silencing of the E2F target genes, such as hTERT. Aim# 3: To elucidate molecular mechanisms by
which IFI16 negatively regulates the transcription of hTERT gene. We will determine whether: (i) knockdown of IFI16
expression in HDFs increases hTERT expression and the telomerase activity; (ii)binding of IFI16 to c-Myc inhibits
dimerization of c-Myc with its partner Max and the c-Myc-mediated transcription; (iii)increases or decreases in the
expression of IFI16 affect binding of c-Myc to hTERT promoter in v/Voand c-Myc-mediated transcription of hTERT
gene. The significance of our proposed experiments is that they will identify molecular mechanisms by which IFI16
regulates the transcription of senescence-associated genes and contributes to the senescence-associated cell cycle
arrest.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8795672
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8481178
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8696826
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8329212
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of Aim2 in Inflammation and Autoimmunity
-
批准号:8317789
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7613399
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7415050
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7091879
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7192486
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7485797
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7914357
-
项目类别:
-
资助金额:$36.1万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7068073
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7740619
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:6959452
-
项目类别:
-
资助金额:$25.25万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI 16 in Cellular Senescence and Aging
-
批准号:6614227
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2003
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2443212
-
项目类别:
-
资助金额:$9.95万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2825892
-
项目类别:
-
资助金额:$11.27万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:6172809
-
项目类别:
-
资助金额:$11.72万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2113102
-
项目类别:
-
资助金额:$9.56万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2733191
-
项目类别:
-
资助金额:$10.83万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
海外基金